For the year ending 2025-12-31, HURA has $27,353,156 in assets. $6,420,828 in debts. $3,619,949 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 3,619,949 | |||
| Stock subscription receivable | 500,000 | |||
| Other current assets | 501,187 | |||
| Total current assets | 4,621,136 | |||
| Property plant and equipment gross | 2,459,351 | |||
| Less accumulated depreciation and amortization | 2,158,712 | |||
| Property and equipment, net | 300,639 | |||
| Operating right-of-use assets | 384,530 | |||
| Other noncurrent assets | 33,769 | |||
| Goodwill | 10,738,082 | |||
| In-process research and development | 11,275,000 | |||
| Total assets | 27,353,156 | |||
| Accounts payable and accrued expenses | 5,522,887 | |||
| Kineta severance promissory notes | 197,354 | |||
| Lease liabilities, current | 199,041 | |||
| Total current liabilities | 5,919,282 | |||
| Lease liability, long term | 303,627 | |||
| Deferred tax liability | 197,919 | |||
| Total liabilities | 6,420,828 | |||
| Preferred stock | 278,530 | |||
| Common stock, 0.001 par value, 200,000,000 and 75,000,000 shares authorized as of december 31, 2025 and 2024 59,336,104 and 12,167,679 shares issued and outstanding as of december 31, 2025 and 2024 | 59,336 | |||
| Additional paid-in capital | 161,779,364 | |||
| Accumulated deficit | -141,184,902 | |||
| Total stockholders' equity | 20,932,328 | |||
| Total liabilities and stockholders' equity (deficit) | 27,353,156 | |||
TuHURA Biosciences, Inc. NV (HURA)
TuHURA Biosciences, Inc. NV (HURA)